Please assess the completion status of the following clinical trial:

Trial Title: Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Informed Consent~* Subject presenting with STEMI undergoing primary PCI~* Patient presents with at least 1 of the following:~* Unstable blood pressure~* Tachycardia and tissue hypoperfusion~* The need for intravenous pressor or inotropic support~* Patient presents with STEMI:~* CK-MB\>2x normal~Exclusion Criteria:~* Unwitnessed cardiac arrest~* Abnormalities of the aorta~* Recent stroke or TIA~* Mural thrombus in the left ventricle

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- IMPELLA LP 2.5 (Type: EXPERIMENTAL): None
- Intra-Aortic Balloon Pump (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).